Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
46.28M
Cash
79.0K
Avg Qtr Burn
-5.384M
Short % of Float
4.33%
Insider Ownership
41.34%
Institutional Own.
12.23%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Troculeucel (SNK01) Details Alzheimer's disease | Phase 1/2 Update | |
SNK01 Details Parkinson's disease, Neurodegenerative disease | Phase 1/2 Initiation | |
SNK02 Details Solid tumor/s, Cancer | Phase 1 Update |